| Description |
1 online resource |
| Series |
Cancer sensitizing agents for chemotherapy ; volume 4 |
|
Cancer sensitizing agents for chemotherapy ; v. 4.
|
| Summary |
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from PDF title page (EBSCO, viewed November 27, 2018) |
| Subject |
Protein-tyrosine kinase -- Inhibitors -- Therapeutic use
|
|
Cancer -- Chemotherapy.
|
|
Protein kinases -- Therapeutic use
|
|
Protein Kinases -- therapeutic use
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Cancer -- Chemotherapy
|
| Form |
Electronic book
|
| Author |
Chen, Zhe-Sheng (Jason), editor
|
|
Yang, Dong-Hua, editor
|
| ISBN |
9780128127384 |
|
0128127384 |
|
9780128164358 |
|
0128164352 |
|
